MENU
APR 02, 2020 6:00 AM PDT

A Multi-Omic Approach to Detection and Characterization of Viral Pathogens and Their Impact on the Immune System

Sponsored by: Fluidigm
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Director, Microfluidics Product Management, Fluidigm
    Biography
      Bill Hunt is a Director of Microfluidics Product Management and has been with Fluidigm for four years. Prior to joining Fluidigm, he was a Marketing Director at Celera Corporation where he managed the commercial relationship with Abbott Molecular, Celera's global distribution partner. Bill earned both Bachelor and Master degrees in Genetics and Molecular Biology from the Pennsylvania State University.
    • Chief Science Officer, Fluidigm
      Biography
        Andrew Quong joined Fluidigm's executive team as Chief Science Officer in June 2019. Prior to this, Andrew was the Director of Strategic Scientific Initiatives and Partnerships at the Frederick National Laboratory for Cancer Research, a federally funded research and development center sponsored by the National Cancer Institute. Frederick National Laboratory is at the forefront of basic, translational and clinical science with a focus on cancer, AIDS and infectious disease. Prior to joining the Frederick National Laboratory, Quong served as a faculty member in the Department of Cancer Biology at Thomas Jefferson University and the Department of Oncology at Georgetown University.

      Abstract

      A growing body of researchers around the world is working to mount an aggressive and sustained response to the COVID-19 pandemic. By building on past successes and harnessing insights from current efforts, the scientific community will be better able to detect and characterize pathogens, identify treatments, and prepare for future outbreaks.

      A comprehensive multi-omic approach is required to understand the complex biological mechanisms involved in SARS-CoV-2 infection, improve the ability to detect and characterize the virus, and assess the subsequent impact on the immune system and the response to therapeutic intervention. Fluidigm microfluidics-based genomic analysis tools and mass cytometry capabilities for highly multiplexed immune cell quantitation are uniquely enabling for virus detection and immune profiling of individuals, and will be increasingly important to government and medical institutions. In this presentation, we will describe our genomic analysis solutions for PCR- and NGS-based applications leveraging the benefits of nanoliter-scale automated microfluidics technology. We will also present the best-in-class immune profiling and monitoring capabilities of mass cytometry, powered by our CyTOF® technology. Our discussion will reflect the use of these tools in research efforts currently underway.


      For Research Use Only. Not for use in diagnostic procedures.


      Show Resources
      You May Also Like
      APR 07, 2020 8:00 AM PDT
      C.E. CREDITS
      APR 07, 2020 8:00 AM PDT
      DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
      JAN 23, 2020 9:00 AM PST
      C.E. CREDITS
      JAN 23, 2020 9:00 AM PST
      DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
      FEB 26, 2020 9:00 AM PST
      C.E. CREDITS
      FEB 26, 2020 9:00 AM PST
      DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
      MAY 08, 2020 10:00 AM PDT
      C.E. CREDITS
      MAY 08, 2020 10:00 AM PDT
      DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
      DEC 05, 2019 9:00 AM PST
      C.E. CREDITS
      DEC 05, 2019 9:00 AM PST
      DATE: December 5, 2019TIME: 9:00am PST, 12:00pm EST Characterization of the spatial distribution and abundance of proteins and mRNAs with morphological context within tissues e...
      DEC 05, 2019 5:00 AM PST
      C.E. CREDITS
      DEC 05, 2019 5:00 AM PST
      DATE: December 5, 2019TIME: 5:00am PST, 8:00am EST The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Ov...
      Loading Comments...
      Show Resources
      Attendees
      • See more